Brain iron uptake and homeostatic mechanisms: An overview

BioMetals

Volumn 16, Issue 1, 2003, Pages 63-75

  Burdo, Joseph R ^a   Connor, James R ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; IRON; IRON TRANSPORT PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; BRAIN METABOLISM; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; HOMEOSTASIS; IRON STORAGE; IRON TRANSPORT; NEUROLOGIC DISEASE; NONHUMAN; REGULATORY MECHANISM;

ANIMALS; BIOLOGICAL TRANSPORT; BRAIN; HOMEOSTASIS; HUMANS; IRON; NEURODEGENERATIVE DISEASES; RECEPTORS, TRANSFERRIN; TRANSFERRIN;

ANIMALIA;

EID: 0037354170     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020718718550     Document Type: Conference Paper

References (118)

1. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. 2001 MRI measurement of brain iron in patients with restless legs syndrome. Neurology 56, 263-265.
2. Arredondo M, Munoz P, Mura CV, Nunez MT. 2001 HFE inhibits apical iron uptake by intestinal epithelial (Caco-2) cells. Faseb J 15, 1276-1278.
3. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM, Hartshorn MA, Tanzi RE, Bush AI. 1998 Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273, 12817-12826.
4. Bacon BR, Fried MW, DiBisceglie AM. 1993 A 39-year-old man with chronic hepatitis, elevated serum ferritin values, and a family history of hemochromatosis. Sem Liver Dis 13, 101-105.
5. Bakshi R, Dmochowski J, Shaikh ZA, Jacobs L. 2001 Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 185, 19-26.
6. Banks WA, Kastin AJ, Fasold MB, Barrera CM, Augereau G. 1988 Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier. Brain Res Bull 21, 881-885.
7. Bartlett WP, Li XS, Connor JR. 1991 Expression of transferrin mRNA in the CNS of normal and jimpy mice. J Neurochem 57, 318-322.
8. Bartzokis G, Beckson M, Hance DB, Marx P, Foster JA, Marder SR. 1997 MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn Resort Imaging 15, 29-35.
9. Bartzokis G, Cummings J, Perlman S, Hance DB, Mintz J. 1999 Increased basal ganglia iron levels in Huntington disease. Arch Neurol 56, 569-574.
10. Bastin JM, Jones M, O'Callaghan CA, Schimanski L, Mason DY, Townsend AR. 1998 Kupffer cell staining by an HFE-specific monoclonal antibody: implications for hereditary haemochromatosis. Br J Haematol 103, 931-941.
11. Benkovic SA, Connor JR. 1993 Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J Comp Neurol 338, 97-113.
12. Berg D, Hoggenmuller U, Hofmann E, Fischer R, Kraus M, Scheurlen M, Becker G. 2000 The basal ganglia in haemochromatosis. Neuroradiol 42, 9-13.
13. Bernstein SE. 1987 Hereditary hypotransferrinemia with hemosiderosis, a murine disorder resembling human atransferrinemia. J Lab Clin Med 110, 690-705.
14. Boado RJ, Pardridge, WM. 1990 The brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier. Biochem Biophys Res Commun 166, 174-179.
15. Bradbury MW. 1997 Transport of iron in the blood-brain-cerebrospinal fluid system. J Neurochem 69, 443-454.
16. Broadwell RD, Brightman MW. 1976 Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood. J Comp Neurol 166, 257-283.
17. Burdo JR, Martin J, Menzies SL, Dolan KG, Romano MA, Fletcher RJ, Garrick MD, Garrick LM, Connor JR. 1999 Cellular distribution of iron in the brain of the Belgrade rat. Neuroscience 93, 1189-1196.
18. Burdo JR, Menzies SL, Simpson IA, Garrick LM, Garrick MD, Dolan KG, Haile DJ, Beard JL, Connor JR. 2001 Distribution of Divalent Metal Transporter 1 and Metal Transport Protein 1 in the Normal and Belgrade Rat. J Neurosci Res 66, 1198-1207.
19. Campbell DR, Skikne BS, Cook JD. 1986 Cerebrospinal fluid ferritin levels in screening for meningism. Arch Neurol 43, 1257-1260.
20. Canonne-Hergaux F, Gruenheid S, Ponka P, Gros P. 1999 Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood 93, 4406-4417.
21. Cavanagh ME, Cornelis ME, Dziegielewska KM, Luft AJ, Lai PC, Lorscheider FL, Saunders NR. 1982 Proteins in cerebrospinal fluid and plasma of fetal pigs during development. Dev Neurosci 5, 492-502.
22. Cavanagh ME, Cornelis ME, Dziegielewska KM, Evans CA, Lorscheider FL, Mollgard K, Reynolds ML, Saunders NR. 1983 Comparison of proteins in CSF of lateral and IVth ventricles during early development of fetal sheep. Brain Res 313
23. Connor JR, Fine RE. 1987 Development of transferrin-positive oligodendrocytes in the rat central nervous system. J Neurosci Res 17, 51-59
24. Connor JR, Menzies SL. 1995 Cellular management of iron in the brain. J Neurol Sci 134 (Suppl), 33-44.
25. Connor JR, Phillips TM, Lakshman MR, Barron KD, Fine RE, Csiza CK. 1987 Regional variation in the levels of transferrin in the CNS of normal and myelin-deficient rats. J Neurochem 49, 1523-1529.
26. Connor J, Menzies S, St. Martin S, Mufson E. 1992a A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 31, 75-83.
27. Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ. 1992b Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res 31, 327-335.
28. Connor JR, Menzies SL, St. Martin SM, Mufson EJ. 1990 Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res 27, 595-611.
29. Connor JR, Milward EA, Moalem S, Sampietro M, Boyer P, Percy ME, Vergani C, Scott RJ, Chorney M. 2001 Is hemochromatosis a risk factor for Alzheimer's disease? J Alzheim Dis 3, 471-477.
30. Connor JR, Menzies SL, Burdo JR, Boyer PJ. 2001 Iron and Iron Management Proteins in Neurobiology. Pediatr Neurol 25, 118-129.
31. Cook JD, Skikne BS, Baynes RD. 1994 Iron deficiency: the global perspective. Adv Exp Med Biol 356, 219-228.
32. Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP, Hay D, Barker WA, Markham AF, Bates D, Curtis A, Burn J. 2001 Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28, 350-354.
33. de Valk B, Addicks MA, Gosriwatana I, Lu S, Hider RC, Marx JJ. 2000 Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 30, 248-251.
34. Deinard AS, List A, Lindgren B, Hunt JV, Chang PN. 1986 Cognitive deficits in iron-deficient and iron-deficient anemic children. J Pediatr 108, 681-689.
35. Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD. 1989 Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 52, 1830-1836.
36. Dexter DT, Carayon A, Javoy-Agid F, Agid Y. Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD. 1991 Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114 (Pt 4), 1953-1975.
37. Dickinson TK, Connor JR. 1995 Cellular distribution of iron, transferrin, and ferritin in the hypotransferrinemic (Hp) mouse brain. J Comp Neurol 355, 67-80.
38. Dobbing J. 1968 The development of the blood-brain barrier. Progr Brain Res 29, 417-427.
39. Earle KM. 1968 Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. J Neurpathol Exp Neurol 27, 1-14.
40. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. 2000 Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 54, 1698-1700.
41. Edwards J, Garrick L, Hoke J. 1978 Defective iron uptake and globin synthesis by erythroid cells in the anemia of the Belgrade laboratory rat. Blood 51, 347-357.
42. Erikson KM, Pinero DJ, Connor JR, Beard JL. 1997 Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. J Nutr 127, 2030-2038.
43. Farcich EA, Morgan EH. 1992 Diminished iron acquisition by cells and tissues of Belgrade laboratory rats. Am J Physiol 262, R220-R224.
44. Faucheux BA, Nillesse N, Damier P, Spik G, Mouatt-Prigent A, Pierce A, Leveugle B, Kubis N, Hauw JJ, Agid Y et al. 1995 Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc Natl Acad Sci USA 92, 9603-9607.
45. Fehling C, Qvist I. 1985 Ferritin concentration in cerebrospinal fluid. Acta Neurol Scand 71, 510-512.
46. Fillebeen C, Descamps L, Dehouck MP, Fenart L, Benaissa M, Spik G, Cecchelli R, Pierce A. 1999 Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem 274, 7011-7017.
47. Fishman J, Rubin J, Handrahan J, Connor J, Fine R. 1987 Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res 18, 299-304.
48. Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews NC. 1998 Nramp2 is mutated in the anemic Belgrade (b) rat: Evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA 95, 1148-1153.
49. Fleming RE, Migas MC, Zhou X, Jiang J, Britton RS, Brunt EM, Tomatsu S, Waheed A, Bacon BR, Sly WS. 1999 Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Proc Natl Acad Sci USA 96, 3143-3148.
50. Forge JK, Pedchenko TV, LeVine SM. 1998 Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. Life Sci 63, 2271-2284.
51. Friden PM, Walus LR, Watson P, Doctrow SR, Kozarich JW, Backman C, Bergman H, Hoffer B, Bloom F, Granholm AC. 1993 Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259, 373-377.
52. Gocht A, Lohler J. 1990 Changes in glial cell markers in recent and old demyelinated lesions in central pontine myelinolysis. Acta Neuropathol 80, 46-58.
53. Griffiths WJ, Sly WS, Cox TM. 2001 Intestinal iron uptake determined by divalent metal transporter is enhanced in HFE-deficient mice with hemochromatosis. Gastroenterololgy 120, 1420-1429.
54. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA. 1997 Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482-488.
55. Haerer AF. 1971 Citrate and alpha-ketoglutarate in cerebrospinal fluid and blood. Neurology 21, 1059-1065.
56. Harris ZL, Klomp LW, Gitlin JD. 1998 Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr 67, 972S-977S.
57. Harris ZL, Durley AP, Man TK, Gitlin JD. 1999 Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA 96, 10812-10817.
58. Hilditch-Maguire P, Trettel F, Passani LA, Auerbach A, Persichetti F, MacDonald ME. 2000 Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum Mol Genet 9, 2789-2797.
59. Hill JM, Switzer RC. 1984 The regional distribution and cellular localization of iron in the rat brain. Neuroscience 11, 595-603.
60. Huggenvik JI, Craven CM, Idzerda RL, Bernstein S, Kaplan J, McKnight GS. 1989 A splicing defect in the mouse transferrin gene leads to congenital atransferrinemia. Blood 74, 482-486.
61. Hulet SW, Hess EJ, Debinski W, Arosio P, Bruce K, Powers S, Connor JR. 1999a Characterization and distribution of ferritin binding sites in the adult mouse brain. J Neurochem 72
62. Hulet SW, Powers S, Connor JR. 1999b Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains. J Neurol Sci 165, 48-55.
63. Hulet SW, Heyliger SO, Powers S, Connor JR. 2000 Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis. J Neurosci Res 61, 52-60.
64. Jaeken J, van Eijk HG, van der Heul C, Corbeel L, Eeckels R, Eggermont E. 1984 Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. Clin Chim Acta 144, 245-247.
65. Jefferies W, Brandon M, Hunt S, Williams A, Gatter K, Mason D. 1984 Transferrin receptor on endothelium of brain capillaries. Nature 312, 162-163.
66. Jefferies WA, Food MR, Gabathuler R, Rothenberger S, Yamada T, Yasuhara O, McGeer PL. 1996 Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Res 712, 122-126.
67. Kalaria R, Sromek S, Grahovac I, Harik S. 1992 Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease. Brain Res 585, 87-93.
68. Keir G, Tasdemir N, Thompson EJ. 1993 Cerebrospinal fluid ferritin in brain necrosis: evidence for local synthesis. Clin Chim Acta 216, 153-166.
69. Kim DK, Seo MY, Lim SW, Kim S, Kim JW, Carroll BJ, Kwon DY, Kwon T, Kang SS. 2001 Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease. Neuropsychopharmacology 25, 84-90.
70. Koeppen AH, Barron KD, Csiza CK, Greenfield EA. 1988 Comparative immunocytochemistry of Pelizaeus-Merzbacher disease, the jimpy mouse, and the myelin-deficient rat. J Neurol Sci 84, 315-327.
71. Leveugle B, Faucheux BA, Bouras C, Nillesse N, Spik G, Hirsch EC, Agid Y, Hof PR. 1996 Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases. Acta Neuropathol 91, 566-572.
72. LeVine SM, Lynch SG, Ou CN, Wulser MJ, Tam E, Boo N. 1999 Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients. Brain Res 821, 511-515.
73. Malecki EA, Cook BM, Devenyi AG, Beard JL, Connor JR. 1999 Transferrin is required for normal distribution of 59Fe and 54Mn in mouse brain. J Neurol Sci 170, 112-118.
74. Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER, Maggio JE. 1993 Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J Neurochem 61, 1171-1174.
75. Martinez di Montemuros F, Tavazzi D, Salsano E, Piepoli T, Pollo B, Fiorelli G, Finocchiaro G. 2001 High frequency of the H63D mutation of the hemochromatosis gene HFE in malignant gliomas. Neurology 57, 1342.
76. Mash DC, Pablo J, Flynn DD, Efange SM, Weiner WJ. 1990 Characterization and distribution of transferrin receptors in the rat brain. J Neurochem 55, 1972-1979.
77. Miller MW, Roskams AJ, Connor JR. 1995 Iron regulation in the developing rat brain: effect of in utero ethanol exposure. J Neurochem 65, 373-380.
78. Moalem S, Percy ME, Andrews DF, Kruck TP, Wong S, Dalton AJ, Mehta P, Fedor B, Warren AC. 2000 Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am J Med Genet 93, 58-66.
79. Mollgard K, Jacobsen M, Jacobsen GK, Clausen PP, Saunders NR. 1979 Immunohistochemical evidence for an intracellular localization of plasma proteins in human foetal choroid plexus and brain. Neurosci Lett 14, 85-90.
80. Moos T. 1995 Developmental profile of non-heme iron distribution in the rat brain during ontogenesis. Develop Brain Res 87, 203-213.
81. Moos T, Morgan EH. 1998a Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid. J Neurosci Res 54, 486-494.
82. Moos T, Morgan EH. 1998b Kinetics and distribution of [59Fe-125I]transferrin injected into the ventricular system of the rat. Brain Res 790, 115-128.
83. Murphy VA, Rapoport SI. 1992 Brain transfer coefficients for 67Ga: comparison to 55Fe and effect of calcium deficiency. J Neurochem 58, 898-902.
84. Ostrerova-Golts N, Petrucelli L, Hardy J, Lee JM, Farer M, Wolozin B. 2000 The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci 20, 6048-6054.
85. Palti H, Meijer A, Adler B. 1985 Learning achievement and behavior at school of anemic and non-anemic infants. Early Hum Develop 10, 217-223.
86. Pardridge WM, Eisenberg J, Yang J. 1985 Human blood-brain barrier insulin receptor. J Neurochem 44
87. Pardridge WM, Eisenberg J, Yang J. 1987 Human blood-brain barrier transferrin receptor. Metabol Cline Exp 36, 892-895.
88. Pardridge WM, Kang YS, Buciak JL. 1994 Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm Res 11, 738-746.
89. Patel BN, David S. 1997 A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem 272, 20185-20190.
90. Pinero D, Connor JR. 2000 Iron In The Brain: an Important Contributor In Normal And Diseased States. Neuroscientist 6, 435-453.
91. Pinero DJ, Li NQ, Connor JR, Beard JL. 2000 Variations in dietary iron alter brain iron metabolism in developing rats. J Nutr 130, 254-263.
92. Rahner-Welsch S, Vogel J, Kuschinsky W. 1995 Regional congruence and divergence of glucose transporters (GLUT1) and capillaries in rat brains. J Cerebr Blood Flow Metabol 15, 204-209.
93. Roberts R, Sandra A, Siek GC, Lucas JJ, Fine RE. 1992 Studies of the mechanism of iron transport across the blood-brain barrier. Ann Neurol 32 (Suppl), 43-50.
94. Roberts RL, Fine RE, Sandra A. 1993 Receptor-mediated endocytosis of transferrin at the blood-brain barrier. J Cell Sci 104 (Pt 2), 521-532.
95. Roskams AJ, Connor JR. 1990 Aluminum access to the brain: a role for transferrin and its receptor. Proc Natt Acad Sci USA 87, 9024-9027.
96. Roskams AJ, Connor JR. 1994 Iron, transferrin, and ferritin in the rat brain during development and aging. J Neurochem 63, 709-716.
97. Rothenberger S, Food MR, Gabathuler R, Kennard ML, Yamada T, Yasuhara O, McGeer PL, Jefferies WA. 1996 Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium. Brain Res 712, 117-121.
98. Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P. 1997 Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nature Gen 17, 215-217.
99. Sampietro M, Caputo L, Casatta A, Meregalli M, Pellagatti A, Tagliabue J, Annoni G, Vergani C. 2001 The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease. Neurobiol Aging 22, 563-568.
100. Sequeira S. 2001 A case of neuroferritinopathy. Trends Neurosci 24, 694.
101. Sindic CJ, Collet-Cassart D, Cambiaso CL, Masson PL, Laterre EC. 1981 The clinical relevance of ferritin concentration in the cerebrospinal fluid. J Neurol Neurosurg Psych 44, 329-333.
102. Sladic-Simic D, Martinovitch PN, Zivkovic N, Pavic D, Martinovic J, Kahn M, Ranney HM. 1969 A thalassemia-like disorder in Belgrade laboratory rats. Ann NY Acad Sci 165, 93-99.
103. Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MB. 1988 Increased iron III and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transmiss 74, 199-205.
104. Spector R, Spector AZ, Snodgrass SR. 1977 Model for transport in the central nervous system. Am J Physiol 232, R73-R79.
105. Swaiman KF. 1991 Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 48, 1285-1293.
106. Tanzi RE, Hyman BT. 1991 Alzheimer's mutation [letter; comment]. Nature 350, 564.
107. Taylor EM, Morgan EH. 1990 Developmental changes in transferrin and iron uptake by the brain in the rat. Develop Brain Res 55, 35-42.
108. Thomas T, Schreiber G, Jaworowski, A. 1989 Developmental patterns of gene expression of secreted proteins in brain and choroid plexus. Dev Biol 134, 38-47.
109. Tu JB, Shafey H, VanDewetering C. 1994 Iron deficiency in two adolescents with conduct, dysthymic and movement disorders. Can J Psychiatry 39, 371-375.
110. Ueda F, Raja KB, Simpson RJ, Trowbridge IS, Bradbury MW. 1993 Rate of 59Fe uptake into brain and cerebrospinal fluid and the influence thereon of antibodies against the transferrin receptor. J Neurochem 60, 106-113.
111. Valk J, van der Knaap MS. 1991 White matter disorders. Curr Opin Neurol Neurosurg 4, 843-851.
112. Waldvogel D, van Gelderen P, Hallett M. 1999 Increased iron in the dentate nucleus of patients with Friedrich's ataxia. Ann Neurol 46, 123-125.
113. Xu J, Ling EA. 1994 Studies of the ultrastructure and permeability of the blood-brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers. J Anatomy 184 (Pt 2), 227-237.
114. Yamada T, Tsujioka Y, Taguchi J, Takahashi M, Tsuboi Y, Moroo I, Yang J, Jefferies WA. 1999 Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer's disease. Brain Res 845, 1-5.
115. Yehuda S, Youdim ME, Mostofsky DI. 1986 Brain iron-deficiency causes reduced learning capacity in rats. Pharmacol Biochem Behav 25, 141-144.
116. Zappone E, Bellotti V, Cazzola M, Ceroni M, Meloni F, Pedrazzoli P, Perfetti V. 1986 Cerebrospinal fluid ferritin in human disease. Haematologica 71, 103-107.
117. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. 2001 A novel pantothenate kinase gene PANK2 is defective in Hallervorden- Spatz syndrome. Nat Genet 28, 345-349.
118. Zywicke HA, van Gelderen P, Connor JR, Burdo JR, Garrick MD, Dolan KG, Frank JA, Bulte JWM. 2002 Microscopic R2* Mapping of reduced brain iron in the Belgrade nat. Ann Neurol 52: 102-105.